# A Study to Understand the Effect of Multiple Ascending Doses of PF-07293893 in Healthy Adult Participants

> **NCT06177457** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 88 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** PF-07293893
- **DRUG:** Placebo
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT06177457
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-20
- **Primary completion:** 2024-12-02
- **Final completion:** 2024-12-02
- **Target enrollment:** 88 (ACTUAL)
- **Last updated:** 2024-12-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06177457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06177457, "A Study to Understand the Effect of Multiple Ascending Doses of PF-07293893 in Healthy Adult Participants". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT06177457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*